Disease modifying drugs modulate endogenous secretory receptor for advanced glycation end-products, a new biomarker of clinical relapse in multiple sclerosis

Autor: Sternberg, Zohara, Sternberg, Daniel, Drake, Allison, Chichelli, Trevor, Yu, Jinhee, Hojnacki, David
Zdroj: In Journal of Neuroimmunology 15 September 2014 274(1-2):197-201
Databáze: ScienceDirect